These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23069705)

  • 1. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
    Böckle BC; Stanarevic G; Sepp NT
    J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
    Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A;
    Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of cutaneous lupus erythematosus.
    Kuhn A; Sticherling M; Bonsmann G
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1124-37. PubMed ID: 18042093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The classification and diagnosis of cutaneous lupus erythematosus.
    Kuhn A; Landmann A
    J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
    Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
    Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous paraneoplastic syndrome as an immunologic phenomenon exemplified by paraneoplastic subacute cutaneous lupus erythematosus].
    Trüeb RF; Trüeb RM
    Praxis (Bern 1994); 1999 Oct; 88(44):1803-10. PubMed ID: 10584550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overlap of Sjögren-lupus erythematosus syndrome].
    Trüeb RM; Borelli S; Schmid-Grendelmeier P; Panizzon RG; Burg G
    Hautarzt; 1995 Jul; 46(7):467-71. PubMed ID: 7672985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?
    Böckle BC; Stanarevic G; Ratzinger G; Sepp NT
    Br J Dermatol; 2012 Nov; 167(5):1067-75. PubMed ID: 22816490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
    Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
    J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus.
    Patsinakidis N; Gambichler T; Lahner N; Moellenhoff K; Kreuter A
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2097-2104. PubMed ID: 27431977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of scalp and nails in lupus erythematosus.
    Trüeb RM
    Lupus; 2010 Aug; 19(9):1078-86. PubMed ID: 20693201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ro antibodies and neonatal lupus.
    Petri M; Watson R; Hochberg MC
    Rheum Dis Clin North Am; 1989 May; 15(2):335-60. PubMed ID: 2657894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.
    Provost TT; Watson R; Simmons-O'Brien E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):147-69; quiz 170-2. PubMed ID: 8708014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.